APP and Cognitive impairment: AOE1 effectively attenuated neuropathology and cognitive deficits in APP/PS1 mice and did not induce T cell activation or microhemorrhages, suggesting that it may be a safer and more effective vaccine for AD treatment (Wang, Liu, et al. 2017).